Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | 24.22% | 48.48% | 24.43% | 8.97% | 21.28% |
| Total Depreciation and Amortization | -32.09% | -52.94% | -183.67% | -78.86% | -65.18% |
| Total Amortization of Deferred Charges | -100.00% | -73.20% | 181.97% | -- | -- |
| Total Other Non-Cash Items | 179.96% | -88.95% | -93.43% | -94.81% | -96.22% |
| Change in Net Operating Assets | 54.72% | 105.10% | 139.08% | 184.09% | 125.14% |
| Cash from Operations | -28.05% | -20.34% | -22.48% | -6.83% | 8.80% |
| Capital Expenditure | -57.35% | -9.92% | -10.78% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -1,155.34% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -134.11% | -213.67% | -366.67% | 187.28% |
| Cash from Investing | 91.88% | 10.39% | 67.87% | 71.66% | 84.50% |
| Total Debt Issued | -100.00% | -100.00% | 0.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -104.00% | -247.78% | -- | -- |
| Cash from Financing | -100.00% | 163.08% | 218.62% | 491.99% | 491.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.31% | 455.51% | 529.67% | 377.57% | 355.13% |
